Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lim

Showing results (371-380 of 418) with videos related to

Pageof 42
Sort By:
Journal of Hepatology|April 7, 2009
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BStefan Zeuzem, Edward Gane, Yun-Fan Liaw, et al.
Journal of Viral Hepatitis|September 1, 2025
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review DataGetahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, et al.
Theriogenology|July 6, 2012
Successful vitrification of bovine blastocysts on paper containerY M Kim, S J Uhm, M K Gupta, et al.
Journal of Viral Hepatitis|February 28, 2026
The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional StudySiwaporn Niyomsri, Aaron G Lim, Ambreen Arif, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Journal of Viral Hepatitis|October 14, 2020
Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, PakistanNyashadzaishe Mafirakureva, Aaron G Lim, Gul Ghuttai Khalid, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
IKKβ slows Huntington's disease progression in R6/1 miceJoseph Ochaba, Gianna Fote, Marketta Kachemov, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
Pageof 42

Showing results (371-380 of 418) with videos related to

Sort By:
Pageof 42
Journal of Hepatology|April 7, 2009
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis BStefan Zeuzem, Edward Gane, Yun-Fan Liaw, et al.
Journal of Viral Hepatitis|September 1, 2025
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review DataGetahun Molla Kassa, Aaron G Lim, Melaku Tileku Tamiru, et al.
Theriogenology|July 6, 2012
Successful vitrification of bovine blastocysts on paper containerY M Kim, S J Uhm, M K Gupta, et al.
Journal of Viral Hepatitis|February 28, 2026
The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional StudySiwaporn Niyomsri, Aaron G Lim, Ambreen Arif, et al.
International Journal of Epidemiology|January 9, 2018
Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving eliminationAaron G Lim, Huma Qureshi, Hassan Mahmood, et al.
The Lancet. Gastroenterology & Hepatology|February 24, 2025
Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysisAdelina Artenie, Adam Trickey, Katharine J Looker, et al.
Journal of Viral Hepatitis|October 14, 2020
Cost-effectiveness of screening and treatment using direct-acting antivirals for chronic Hepatitis C virus in a primary care setting in Karachi, PakistanNyashadzaishe Mafirakureva, Aaron G Lim, Gul Ghuttai Khalid, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2019
IKKβ slows Huntington's disease progression in R6/1 miceJoseph Ochaba, Gianna Fote, Marketta Kachemov, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
Wild-type <i>C9orf72</i> expression is a genetic modifier of C9-ALS survivalStanislav Tsitkov, Akshay Raju, Jie Wu, et al.
The Lancet. Gastroenterology & Hepatology|February 5, 2022
Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHOAdelina Artenie, Niklas Luhmann, Aaron G Lim, et al.
Pageof 42